Go to deals
Healthcare

Bioventix has completed a US$1.4 million sell-down of founder’s equity

Bioventix Plc has raised funds through a sell-down of the founder’s equity.

Bioventix was founded in 2003 as a biotechnology company specializing in the creation and supply of high-affinity sheep monoclonal antibodies (SMAs) for use in immunodiagnostics such as clinical blood testing.

Oaklins Cavendish’s sister firm finnCap, based in the UK, acted as financial advisor and broker in respect of the sell-down of the founder’s equity.

Talk to the deal team

 Geoff  Nash

Geoff Nash

Director
London, United Kingdom
Oaklins Cavendish

Related deals

Aenza S.A.A. has completed a follow-on
Private Equity | Construction & Engineering Services | Energy | Real Estate

Aenza S.A.A. has completed a follow-on

Aenza S.A.A. has completed af follow-on to prepay part of a recently renegotiated bridge loan.

Learn more
move UP has been acquired by Acture B.V.
Private Equity | Business Support Services | Healthcare

move UP has been acquired by Acture B.V.

move UP Gesellschaft für Gesundheitsmanagement mbH, an innovative provider of holistic corporate health management solutions, has been acquired by Acture B.V., a leader in welfare management. This acquisition represents a major step in Acture’s plans to expand into the German corporate health management sector.

Learn more
Pampa Camarones has completed an IPO
Other Industries

Pampa Camarones has completed an IPO

Pampa Camarones SpA has successfully raised US$5 million through its stock market debut on ScaleX (Santiago Venture Exchange). These funds will be used to extend the mine life and incorporate the high-grade polymetallic project, Ciclón Exploradora.

Learn more